Quotes for Ectin Research AB
Right Now
- +/-
- %
- Latest
- High
- Low
- Volume
- Turnover ()
- Time (Latest trade)
Board
CEO
- Anna Sjöblom-Hallén
Chairperson of the Board
- Hans-Peter Ostler
Board
- Christer Edlund
- Fredrik Andersson
- Göran Gannedahl
- Marie-Lois Ivarsson
Ectin Research AB
Ectin Research is active in biotechnology. The company specializes in research and development of drug candidates. The research is focused on developing drugs that aim to eliminate cancerous tumors in patients, with the greatest focus on the treatment of bladder cancer. In addition, the company intends to develop drugs for the treatment of breast, colorectal and prostate cancer cells.
News
- Ectin Research AB (publ) publicerar delårsrapport för perioden 1 januari – 30 juni 2024
- Bolagsverket har den 15 augusti beslutat om att godkänna bolagets likvidation. Till likvidator har Urban Hjelm utsetts.
- Kommuniké från extra bolagsstämma tillika första kontrollstämma i Ectin Research AB
- Ectin Research AB har idag skickat in en ansökan om avnotering av bolagets aktie från Spotlight Stock Market
- Kallelse till extra bolagsstämma, tillika första kontrollstämma, i Ectin research AB (publ)
Largest Owners
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| JRS Asset Management AB Client Account | 9,84 | 4,50 | 2024-06-26 |
| Avanza Pension | 8,17 | 3,74 | 2024-06-26 |
| Peter Falk | 4,35 | 19,63 | 2024-06-26 |
| Ivarsson Medical Research AB | 4,33 | 19,62 | 2024-06-26 |
| Christer Edlund | 4,33 | 19,62 | 2024-06-26 |
| Fredrik Andersson | 3,95 | 1,81 | 2022-04-12 |
| Moll Invest AB | 3,28 | 1,50 | 2024-06-26 |
| GU Ventures | 2,70 | 1,23 | 2024-06-26 |
| Power Capital Society AB | 2,20 | 1,00 | 2024-06-26 |
| GOKAP Invest AB | 2,06 | 0,94 | 2024-06-26 |
Insider trading
*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority
Key Numbers
*Compiled data from Millistream